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Abstract
Objective: To bring together stakeholders in the United Kingdom to establish national
priorities for research in single-ventricle heart conditions. Methods: This study
comprised two surveys and a workshop. The initial public online survey asked
respondents up to three questions they would like answered for research. Responses
were classified as unanswered, already answered, or unable to be answered by scientific
research. In the follow-up survey, unanswered questions were divided into categories and
respondents were asked to rank categories and questions by priority. A stakeholder
workshop attended by patients, parents, healthcare professionals, researchers, and
charities was held to determine the final list of research priorities. Results: A total of 128
respondents posed 344 research questions, of which 271 were classified as unanswered,
and after removing duplicates, 204 questions remained, which were divided into 20
categories. In the second survey, 56 (49.1%) respondents successfully ranked categories
and questions. A total of 39 participants attended the workshop, drawing up a list of 30
research priorities across nine priority categories. The nine priority categories are:
Associated co-morbidities; Brain & neurodevelopment; Exercise; Fontan failure; Heart
function; Living with a single ventricle heart condition; Management of the well-
functioning Fontan circulation; Surgery & perioperative care; and Transplantation,
mechanical support & novel therapies. Conclusions: Through a multi-stage process, we
engaged a wide range of interested parties to establish a list of research priorities in
single-ventricle heart conditions. This provides a platform for clinicians, researchers, and
funders in the United Kingdom and elsewhere to address the most important questions
and improve outcomes in these rare but high-impact CHDs.
Single-ventricle heart conditions are a collection of congenital cardiac defects in which one
of the ventricles is insufficiently developed or compromised such that it is unable to support
an adequate cardiac output. With an incidence of 2–3 in 10,000 live births,1,2 it includes
diagnoses such as hypoplastic left heart syndrome, tricuspid atresia, and unbalanced
atrioventricular septal defect. Although initial surgical palliation varies by type, their paths
commonly converge around 3–4 years of age to undergo the Fontan procedure,3 whereby the
functioning ventricle is used to support the systemic circulation with passive blood flow in
series to the lungs. The success of surgical programmes over the last 30 years has led to an
increasing number of children and adults living with a Fontan circulation, currently esti-
mated at over 3000 in the United Kingdom,1 and up to 70,000 worldwide,4 with the
population predicted to double over the next 20 years in developed countries.1,5 However,
this inherently inefficient circulation predisposes to multiple late complications,6,7 with half
affected by a major complication before reaching adulthood.8 A 40-year-old patient with
Fontan physiology has an 18% 5-year risk of death, comparable to that of a 75-year-old in
the general population of United Kingdom.9
Patients with single-ventricle heart conditions have complex healthcare needs, requiring
multiple operations often from birth and lifelong, multi-disciplinary follow-up in specialist cen-
tres.10 Ongoing physiological and psychosocial issues place a considerable burden on patients and
their families with a significant reduction in quality of life.11 Although there are expectations of
improving outcomes,12 the Fontan circulation remains a life-limiting condition with limited
treatment options; it is the highest risk diagnosis for heart transplantation, yet is the least amenable
to mechanical circulatory support.13 Consequently, there is a demand for research to understand
the impact of living with this condition and improve outcomes for patients and families
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throughout their journey. The International Fontan Interest Group
has been established as a collaborative initiative to improve out-
comes and has called for engagement of stakeholders to direct
research priorities.4 We therefore brought together interested parties
in the United Kingdom to establish priorities for research in single-
ventricle heart conditions.
Materials and methods
The study was developed in collaboration with Little Hearts Matter,
the United Kingdom national charity for single-ventricle heart con-
ditions.14 As it blurred the boundaries between scientific research and
public engagement,15 approval was obtained from the Ethical Review
Committee, University of Birmingham (ERN_17-0902). Our meth-
odology was informed by the James Lind Alliance16 and Cochrane
Tobacco Addiction Group,15 as we explicitly aimed to reach a wide
range of stakeholders including patients, their relatives, healthcare
professionals, researchers, charities, funders, and policymakers. The
study comprised three stages: an initial public survey; a follow-up
ranking survey of respondents; and a workshop of invited parties.
Stage 1 survey: identifying gaps in knowledge
An initial cross-sectional, self-administered, public survey was
conducted using REDCap, a secure online platform.17 An elec-
tronic link was disseminated by two national patient charities,
Little Hearts Matter and The Somerville Foundation, via e-mail,
newsletters, and social media such as Facebook and twitter. Pro-
fessional groups were contacted via the organisational mailing lists
of the British Congenital Cardiac Association (BCCA), Society for
Cardiothoracic Surgery (SCTS) and Paediatric Intensive Care
Society Study Group (PICS-SG), and publicised at national
meetings. United Kingdom-based researchers, heart charities,
research funders, and National Health Service commissioners of
congenital heart services were contacted directly via e-mail.
Respondents were asked: “What questions would you like to
see answered by future research for patients who have a single-
ventricle heart condition?” and invited to pose up to three
questions. Additional demographic data was collected on their
role, age (patients), relationship with a patient (relatives), and
institution (professionals). Consent was obtained for the storage,
analysis, and anonymous reporting of data, and a study e-mail
address was provided to enable withdrawal of consent and/or
data, if required. Respondents were asked to provide their name
and e-mail address to allow re-contact for stage 2.
The survey remained open for 12 weeks after which all
responses were collated and reviewed according to a pre-
determined process.15 Submitted questions were screened by at
least two reviewers (N.E.D., V.M.S., C.J.B., A.J.P.) to remove
duplicates and any that fell outside the scope of the study. The
remaining questions were rephrased for clarity and consistency of
terminology, as required, and classified according to the current
literature: as unanswered by current research; already answered by
published research; or unable to be answered by scientific research.
Any disagreements were resolved by consensus, involving an
additional reviewer (P.F.C.) when necessary. Questions considered
unable to be answered by research were discarded whereas those
most commonly deemed to be already answered were collated and
lay summaries of the explanation with supporting evidence pub-
lished in the Little Hearts Matter newsletter. Valid unanswered
research questions were allocated into one or more topic categories
according to emerging themes and progressed to the next stage.
Stage 2 survey: prioritising gaps in knowledge
Respondents who provided an e-mail address were sent a per-
sonalised link to a second REDCap survey, enabling tracking of
responses and targeted reminders. Participants were asked to rank
the emerging research categories of stage 1 in order of priority for
future research, from 1= “most important” to 20= “least
important”. For their top three categories, they were asked to
similarly rank each question within each category.15
The second survey remained open for 4 weeks with a reminder
sent after 2 weeks. Fisher’s exact test was used to compare
response rates. Any responses with insufficient data were exclu-
ded. Completed responses were collated and categories assigned a
score inversely proportional to their ranking, such that the
highest-ranked scored 20 points down to 1 point for the lowest-
ranked; a category received an additional 10 points each time it
was ranked in a respondent’s top three. By combining these scores,
the highest-ranking categories were taken forward to the next
stage, along with the 5–7 highest ranking questions in each.
Stage 3 workshop: establishing research priorities
Participants were invited to take part in the workshop to repre-
sent all those affected by, caring for, or conducting research into
single-ventricle heart conditions. An iterative process of invitation
was used to ensure an adequate balance by role, age/experience,
gender, and location, with the first invitations sent out 8 weeks in
advance. Patients and parents who had responded to the surveys
were contacted via e-mail, with further participants recruited via
social media. A broad range of healthcare professionals were
invited from every tertiary CHD programme in England.
Workshop participants were provided with a booklet in
advance, containing information about the study and the list of
categories and questions prioritised at stage 2. Written consent
was obtained for participation, digital recording of discussions,
data sharing, and being named as a collaborator. The workshop
comprised small and large group discussions chaired and
facilitated by N.E.D., with participants seated at round tables of
six or seven according to a pre-determined plan to achieve
mixed groups by role, experience, and location; this ensured that
patients/parents were not on the same table as their direct
healthcare providers. All participants were encouraged to share
their views, respect the views of others, and ensure that they all
had the opportunity to express their opinions. Specialist nurses
and charity representatives were available throughout the day so
that participants could talk through any difficult issues in a
private breakout room.
In the morning, the small groups were asked to identify which
five categories were highest priority for their table and present
their choices and reasons to the whole group. Over lunch,
responses were collated using a nominal group technique to
generate a final list of nine priority categories and these were fed
back to the whole group. The small groups were then allocated
three priority categories that they had chosen such that each
category was independently reviewed by two tables. They were
asked to prioritise three questions within each of these categories,
present their choices to the whole group, and following discus-
sion, group consensus was sought on the three most important
questions in each category. The workshop closed with an open
discussion on how the community should take forward research
in single-ventricle heart conditions. Anonymous feedback cards
were provided and individual comments collated.
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Results
Stage 1 survey
The initial survey was open from 9 October to 31 December,
2017. A total of 128 individuals completed the online form, of
whom 49 (38.3%) were adult patients or family members
(Table 1); patients ranged from 16–24 years to 65 + years.
Although it is assumed that most respondents were from the
United Kingdom, responses are known to have been submitted
from professionals in continental Europe, North America, and
Africa.
Respondents posed 340 research questions: 94 with three
questions, 24 with two questions, and 10 with one question; on
review, four composite questions were split to improve clarity,
giving a total of 344 questions. Of these, 271 (78.8%) were clas-
sified as unanswered, 26 (7.6%) as already answered, and 47
(13.7%) as unable to be answered. After removing duplicates and
rephrasing for clarity and consistency as required, 204 unan-
swered questions remained which were divided into 20 categories
according to emerging themes.
Stage 2 survey
A total of 114 (89.1%) respondents to stage 1 provided an e-mail
address and were re-contacted in February 2018. Of 114
respondents, 65 (57.0%) completed the follow-up ranking survey,
of whom 25 (38.5%) were adult patients or family members
(Table 1); there was no significant difference between the
response rates of patients/family members and healthcare pro-
fessionals (p= 0.85). Nine (13.8%) responses were discarded due
to insufficient data or inappropriate completion and 56 (86.2%)
were analysed. The scoring of categories and frequency of ranking
in the top three are shown in Table 2. A full list of the categories
and questions taken forward to the workshop is documented in
the supplementary material.
Stage 3 workshop
The final-stage workshop was held in a meeting venue in central
Birmingham, United Kingdom on Monday 23 April, 2018 and
was attended by 39 participants representing a wide range of
perspectives (Table 1). An additional 10 adult patients, 5 parents,
12 healthcare professionals, and 2 researchers were invited during
the iterative process but declined; healthcare professionals from
all 10 tertiary CHD programmes in England were invited of
which six were represented; see the list of collaborators. They
were categorised into nine categories were prioritised by at least
two tables and taken forward. On discussing the questions in each
category, there was a lack of consensus in two categories, and it
was agreed that more than three questions would be retained as
priorities in each. The workshop felt that some questions should
be reworded to combine the aspects of separate questions. Fur-
thermore, the group felt it was important to broaden the category
of transplantation, mechanical support, and stem cell therapy by
renaming it as transplantation, mechanical support, and novel
therapies as there was apprehension over the unproven role of
stem cells, despite much interest from survey respondents. The
final list of 30 research priorities determined by the workshop is
shown in Table 3.
In the closing discussions, several key themes emerged:
∙ Collaboration among the United Kingdom CHD community,
to bring together all centres in a network and establish a
working group of key stakeholders;
Table 1. Roles of participants in the surveys and workshop.
Role Initial survey stage 1 (n= 128) Ranking survey stage 2 (n= 65) Workshop stage 3 (n= 39)
Adult patients 7 2 4
Patient family members 42 23 5
Parents 38 20 5
Partners 3 3 0
Child 1 0 0
Healthcare professionals 71 34 23
Paediatric cardiologists 13 6 5
Adult congenital cardiologists 9 7 4
Cardiac surgeons 13 7 7
Cardiac anaesthetists/intensivists 9 4 1
Paediatric nurses 15 5 3
Adult congenital nurses 3 2 2
Other* 8 3 1
Researchers 7 5 4
Charity representatives 1 1 3
Policymakers 0 0 0
*Stage 1: 2 cardiac physiologists, 2 cardiac radiologists, 1 clinical perfusionist, 1 data analyst, 1 paediatrician with expertise in cardiology, 1 surgical care practitioner. Stage 2: 1 cardiac
radiologist, 1 data analyst, 1 paediatrician with expertise in cardiology. Stage 3: 1 clinical geneticist.
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∙ Establishment of a national registry for the long-term follow-
up of patients with single-ventricle heart conditions, learning
from the experiences of the Australia and New Zealand
Fontan Registry;12
∙ Standardisation of follow-up protocols and recording of a
core set of variables to facilitate the registry;
∙ The importance of continuing to involve patients, their
families, and charities in these processes;18
∙ The need for diverse research methodologies to answer the
prioritised questions;
∙ Engagement with multi-disciplinary researchers, such as
engineers, biologists, geneticists, social scientists and industry,
and with colleagues across the world through the Interna-
tional Fontan Interest Group.4
Finally, all patients and parents agreed that their voices had
been heard during the workshop and this was supported by
individual comments on anonymous feedback cards.
Discussion
Prioritisation of research through consultation with those affected
by or caring for those with a disease ensures that it remains
directly relevant to improving their lives. In this study, we sought
to establish priorities for research in single-ventricle heart con-
ditions by engaging with a wide range of stakeholders, including
adult patients, parents, healthcare professionals, researchers, and
charities. Through a multi-stage process, we compiled a list of
potential questions, filtered out those already answered or
unanswerable, removed duplicates, rephrased for clarity and
consistency, re-consulted to prioritise questions, convened a
diverse group of interested parties, and produced a validated final
list of priorities. To our knowledge, this study is the first to bring
together stakeholder groups to establish specific priorities for
research in single-ventricle heart conditions and thereby shape
the research agenda.
Several studies have assessed research priorities in CHD
including single-ventricle heart conditions. Cotts et al for the
Alliance for Adult Research in Congenital Cardiology compiled a
list of 45 questions and conducted a survey of providers to
identify 10 priority questions, with some input from patient
groups.19 Of these, four were specific to patients with single-
ventricle heart conditions: “Is pulmonary vasodilator therapy
beneficial in Fontan patients?”, “Are warfarin and/or aspirin
beneficial in preventing primary thromboembolic events in adult
Fontan patients?”, “What is the optimal medical therapy for
preservation of ventricular systolic and diastolic function in
Fontan patients?” and “What is the optimal medical treatment
algorithm for Fontan patients with protein-losing enteropathy?”,
whereas another was also relevant: “What are the ideal criteria for
transplantation referral in ACHD?”. Similar questions to each of
these were posed in our initial survey but only preservation of
ventricular function was included as a priority. Helm et al
Table 2. Scoring of categories in the ranking survey (stage 2).
Category Ranking points Rank #1 Rank #2 Rank #3 Rank #1-3 Total score Proceed to workshop
Fontan failure 818 11 10 5 26 1078 Yes
Transplantation, mechanical support and stem cell therapy 658 10 2 5 17 828 Yes
Heart function 713 6 4 0 10 813 Yes
Outcomes of current treatments 691 6 1 5 12 811 Yes
Management of the well-functioning Fontan circulation 666 4 6 3 13 796 Yes
Anticoagulation 646 2 4 5 11 756 Yes
Alternatives to a Fontan circulation 585 3 6 5 14 725 Yes
Associated co-morbidities 649 0 4 3 7 719 Yes
Living with a single-ventricle heart condition 638 0 2 4 6 698 Yes
Quality of life 617 4 3 1 8 697 Yes
Arrhythmias 623 3 1 3 7 693 Yes
Exercise 618 0 2 3 5 668 Yes
Brain and neurodevelopment 594 1 1 5 7 664 Yes
Surgery and perioperative care 527 2 2 4 8 607 Yes
Low oxygen saturations/cyanosis 566 1 0 0 1 576 –
Counselling and parental support 518 0 3 1 4 558 –
Liver function 520 0 3 0 3 550 –
Psychological impact 498 2 1 1 4 538 –
Causes of single-ventricle heart conditions 488 0 2 3 5 538 –
Pulmonary vascular development and function 451 1 0 1 2 471 –
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conducted an online survey of adult patients, relatives, and physi-
cians to prioritise pre-determined research topics, including in the
Fontan circulation;20 priorities included the failing Fontan, catheter
ablation and rhythm disorders, sex and pregnancy, diagnostic
imaging, and quality of life. Finally, McCrindle et al convened a
working group to explore issues specific to thrombosis in children,
including those with single-ventricle heart conditions;21 despite not
including patients or the public in the group, they concluded that
patients and their families are important stakeholders in designing
successful studies and identified patients with a single ventricle as a
priority population for research.
The priorities identified in our study comprise 30 research
questions across nine categories. Several categories which scored
highly in the ranking survey (Table 2), notably outcomes of cur-
rent treatments, anticoagulation, and alternatives to Fontan, were
deemed less important by the workshop participants than some
lower ranking categories: exercise, brain and neurodevelopment,
and surgery and perioperative care. This may reflect specific
interests of those attending the workshop or that recognition of
the importance of these categories was elevated through the
Table 3. Final list of research priorities determined by the workshop (stage 3).
Category Research question
Associated co-morbidities What are the outcomes in children with
multiple co-morbidities?
What are the common co-morbidities in
children with a single-ventricle heart
condition?
What is the impact of syndromes or other
co-morbidities on the quality of life of
those with a single-ventricle heart
condition and their families?
Brain and neurodevelopment What factors influence
neurodevelopmental outcomes in
children with single-ventricle heart
conditions?
Are there differences in brain
development in the fetus with a single-
ventricle heart condition and if so,
what is the impact on outcomes?
What is the impact of a single-ventricle
heart condition on neurodevelopment?
Exercise What are the effects of regular physical
exercise on well-being and long-term
outcome in the Fontan circulation?
What type of exercise is most beneficial in
those with a Fontan circulation?
What are the benefits of exercise
rehabilitation in well and deteriorating
patients with a Fontan circulation?
Fontan failure What are the best markers of
deterioration in patients with a Fontan
circulation?
What is the main mechanism behind
failure of the Fontan circulation?
How can we prevent late multi-organ
dysfunction in the Fontan circulation?
Heart function What is the cause of ventricular
dysfunction in the single ventricle?
How can ventricular function be best
preserved in patients with a single-
ventricle heart condition?
What treatments can be developed for
ventricular failure in patients with a
Fontan circulation?
Living with a single-ventricle
heart condition
What are the frequencies of symptoms,
limitations, physical, and emotional
quality of life with a Fontan
circulation?
What lifestyle choices (e.g. diet, exercise,
occupation, physical location) best
support the long-term health of
patients with a single-ventricle heart
condition?
What are the long-term social,
psychosocial, and other non-clinical
outcomes of children with single-
ventricle heart conditions?
Table 3. (Continued )
Category Research question
Which models of care, virtual ward and
home monitoring programmes, best
support infants, children and young
people with a single-ventricle heart
condition at home?
Management of the well-
functioning Fontan
circulation
How can the longevity of the Fontan
circulation be prolonged?
How can organ function be optimised in
patients with a Fontan circulation?
What factors best determine a well-
functioning Fontan circulation?
What is the optimal interval for follow-up
of patients with a Fontan circulation?
What is the impact of pregnancy on
patients with a Fontan circulation and
how can outcomes be improved?
Surgery and perioperative care Which modifiable perioperative factors
can reduce mortality for the Norwood
operation?
How can perinatal risk stratification be
used to identify those in whom the
Norwood operation is futile?
How could technology be used to
perform a biventricular repair in
patients with a single-ventricle heart
condition?
Transplantation, mechanical
support, and novel therapies
How can mechanical assist devices be
developed to support the Fontan
circulation?
What are the roles of novel therapies in
the failing Fontan?
What are the alternatives to
transplantation for the failing Fontan?
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workshop discussions. In addition, quality of life was felt to sig-
nificantly overlap with aspects of other categories which ranked
higher. The final list of priorities addresses a wide range of issues
impacting on those affected by single-ventricle heart conditions –
from perinatal decision-making to late multi-organ dysfunction,
surgical technology to lifestyle choices, and mechanisms of dis-
ease to quality of life. Consequently, diverse methodologies will be
required to address these questions, including surveys, qualitative
studies, translational research, and clinical trials, driving colla-
boration within the CHD community and across disciplines. Our
findings will be publicised nationally, including in charity news-
letters and via social media, and we will engage with the National
Institute for Health Research, other research funders, and
National Health Service specialised commissioning to promote
awareness of the priorities identified.22
In this study, we deliberately adopted an approach different to
that advocated by the James Lind Alliance to enable us to engage
with stakeholders beyond patients, carers, and clinicians.16 We
also wanted to generate more than 10 priority questions as single-
ventricle heart conditions are lifelong, multi-system disorders that
impact on patients and their families throughout their lives. Other
strengths included triangulation of the survey and workshop to
provide different perspectives, reduce bias, and enhance the
validity of the findings;23 engagement with a wide range of
healthcare professionals involved in the care of these patients;
mixed yet balanced groups on each table to facilitate open dis-
cussion, whilst avoiding seating patients or parents with their
direct healthcare providers; and obtaining funding to cover travel
expenses for patients and parents to attend the workshop. In
addition, it provided an opportunity to resolve questions already
answered by published research, educate and dispel myths in the
wider community.
Limitations
There were several limitations to this study. First, the mechanisms
used to publicise the survey attracted a predominately United
Kingdom-based audience potentially limiting the international
applicability of the questions generated, although there were
known to be responses from elsewhere; in addition, the workshop
attendees were exclusively living or working in the United
Kingdom which may have impacted on which categories and
research questions were prioritised. The number of adult patients
who replied to the initial survey was lower than expected but the
response from parents was encouraging. This may have shifted
the focus towards paediatric matters, such as diagnosis and sur-
gery, with less attention on later issues, such as longevity and end
of life care, although the two highest ranking categories were
Fontan failure and transplantation. We invited a range of clinical
and research policymakers to participate in the study but none
responded, thereby reducing the scope of potential questions
regarding resource utilisation and comparative effectiveness. The
second stage of the survey was more complex than the first which
may have reduced the response rate and the software was not able
to adequately enforce the rules for completion, leading to the
exclusion of nine incomplete or inappropriate responses. The
workshop was held on a weekday to facilitate attendance by
healthcare professionals but was seen to impact on the ability of
working patients and parents to attend, either directly or through
the need for childcare; this may also have skewed the demo-
graphic of those present. Furthermore, there was no specific travel
funding for professional attendees which may have impacted on
how far they were prepared to travel. Finally, our two centres in
Birmingham were disproportionately represented at the work-
shop; although we have the largest surgical and adult programmes
for the management of these conditions in the United Kingdom,24
the debate could have been unduly influenced by local practices
and the final list of priorities has not been externally validated.
Conclusions
We used a multi-stage process to bring together all interested
parties to establish a list of priorities for research in single-
ventricle heart conditions. Our findings provide a platform for
clinicians, researchers, and funders in the United Kingdom and
elsewhere to address the most important questions and drive
forward research to improve outcomes in these rare but high-
impact CHDs.
Supplementary material. To view supplementary material for this article,
please visit https://doi.org/10.1017/S104795111800224X
Acknowledgements. The authors thank all those who responded to our
surveys by posing or ranking questions for research. They are grateful to Rita
Perry at Birmingham Clinical Trials Unit for her assistance with Research
Electronic Data Capture (REDCap), and Dr Olga Vikhireva at NIHR Research
Design Service West Midlands for her guidance on patient and public
involvement. They thank Little Hearts Matter, the Somerville Foundation, the
British Congenital Cardiac Association (BCCA), the Society for Cardiothor-
acic Surgery in Great Britain & Ireland (SCTS) and the Paediatric Intensive
Care Society Study Group (PICS-SG) for circulating the initial survey to their
membership.
The study data were collected and managed using REDCap electronic data
capture tools hosted at the University of Birmingham. REDCap is a secure,
web-based application designed to support data capture for research studies,
providing an intuitive interface for validated data entry; audit trails for
tracking data manipulation and export procedures; automated export
procedures for seamless data downloads to common statistical packages;
and procedures for importing data from external sources.17
Contributors. N.E.D., S.H., and P.F.C. devised the study. N.E.D., V.M.S., and
P.F.C. obtained funding. N.E.D. coded the electronic surveys. N.E.D., V.M.S.,
C.J.B., and A.J.P. reviewed the questions and revised the wording, with P.F.C.
as the additional reviewer, as required. N.E.D. chaired the workshop which
was attended by all authors and collaborators. N.E.D. wrote the first draft of
the manuscript which was critically revised by all authors.
Financial Support. Nigel Drury is funded by an Intermediate Clinical
Research Fellowship from the British Heart Foundation (FS/15/49/31612) and
Victoria Stoll holds a National Institute for Health Research Academic Clinical
Lectureship. Patient and parent travel to the workshop was funded by a
bursary from the Patient Involvement Fund (PIF-2380) of the NIHR West
Midlands Research Design Service. This research received no specific grant
from any funding agency, commercial or not-for-profit sectors.
Conflicts of Interest. Dr Clift has received consultancy fees and honoraria
from Actelion Pharmaceuticals Ltd. No other authors declare a potential
conflict of interest.
Ethical Standards. The authors assert that this work complies with the
ethical standards of the relevant national guidelines and with the Helsinki
Declaration of 1975, as revised in 2008, and has been approved by the Ethical
Review Committee at the University of Birmingham, United Kingdom.
References
1. Coats L, O’Connor S, Wren C, et al. The single-ventricle patient
population: a current and future concern a population-based study in the
North of England. Heart 2014; 100: 1348–1353.
6 N. E. Drury et al
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S104795111800224X
Downloaded from https://www.cambridge.org/core. University of Birmingham, on 22 Jan 2019 at 14:31:06, subject to the Cambridge Core terms of use, available at
2. Qu Y, Liu X, Zhuang J, et al. Incidence of congenital heart disease: the 9-
year experience of the Guangdong registry of congenital heart
disease, China. PLoS One 2016; 11: e0159257.
3. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971; 26:
240–248.
4. d’Udekem Y, Rychik J. Towards the goal of achieving a normal duration
and quality of life after Fontan operation: Creation of the International
Fontan Interest group (I-FIG), an international collaborative initiative
dedicated to improving outcomes. Int J Cardiol 2017; 245: 131–134.
5. Schilling C, Dalziel K, Nunn R, et al. The Fontan epidemic: population
projections from the Australia and New Zealand Fontan Registry. Int J
Cardiol 2016; 219: 14–19.
6. Gewillig M, Brown SC. The Fontan circulation after 45 years: update in
physiology. Heart 2016; 102: 1081–1086.
7. Rychik J, Goldberg DJ. Late consequence of the Fontan operation.
Circulation 2014; 130: 1525–1528.
8. Iyengar AJ, Winlaw DS, Galati JC, et al. The extracardiac conduit Fontan
procedure in Australia and New Zealand: hypoplastic left heart syndrome
predicts worse early and late outcomes. Eur J Cardiothorac Surg 2014; 46:
465–473.
9. Diller GP, Kempny A, Alonso-Gonzalez R, et al. Survival prospects and
circumstances of death in contemporary adult congenital heart disease
patients under follow-up at a large tertiary centre. Circulation 2015; 132:
2118–2125.
10. Rychik J. The relentless effects of the Fontan paradox. Semin Thorac
Cardiovasc Surg Pediatr Card Surg Ann 2016; 19: 37–43.
11. Uzark K, Zak V, Shrader P, et al. Assessment of quality of life in young
patients with single ventricle after the Fontan operation. J Pediatr 2016;
170: 166–172.
12. d’Udekem Y, Iyengar AJ, Galati JC, et al. Redefining expectations of
long-term survival after the Fontan procedure. Circulation 2014; 130:
S32–S38.
13. Kirklin JK, Pearce FB, Dabal RJ, et al. Challenges of cardiac transplanta-
tion following the Fontan procedure. World J Pediatr Congenit Heart
Surg 2017; 8: 480–486.
14. Little Hearts Matter. https://www.lhm.org.uk/ [accessed August 2018].
15. Lindson N, Richards-Doran D, Heath L, et al. Setting research priorities in
tobacco control: a stakeholder engagement project. Addiction 2017; 112:
2257–2271.
16. James Lind Alliance. JLA Guidebook. http://www.jla.nihr.ac.uk/jla-guide
book/ [accessed August 2018].
17. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture
(REDCap) – a metadata-driven methodology and workflow process for
providing translational research informatics support. J Biomed Inform
2009; 42: 377–381.
18. d’Udekem Y, Forsdick V, du Plessis K. Involvement of patients and
parents in research undertaken by the Australian and New Zealand
Fontan Registry. Cardiol Young 2018; 28: 517–521.
19. Cotts T, Khairy P, Opotowsky AR, et al. Clinical research priorities in
adult congenital heart disease. Int J Cardiol 2014; 171: 351–360.
20. Helm PC, Körten MA, Abdul-Khaliq H, et al. Three parties, one direction:
research priorities in adults with congenital heart disease. What do professionals,
patients and relatives want to know? Int J Cardiol 2016; 207: 220–229.
21. McCrindle BW, Li JS, Malhiot C, et al. Challenges and priorities for
research: a report from the National Heart, Lung, and Blood Institute
(NHLBI)/National Institutes of Health (NIH) working group on
thrombosis in pediatric cardiology and congenital heart disease.
Circulation 2014; 130: 1192–1203.
22. Chalmers I, Bracken MB, Djulbegovic B, et al. How to increase value and
reduce waste when research priorities are set. Lancet 2014; 383: 156–165.
23. Lincoln YS, Guba EG. Naturalistic enquiry. Sage: Beverly Hills, CA, 1985.
24. NICOR National Institute for Cardiovascular Outcomes Research.
National Congenital Heart Disease Audit. https://nicor4.nicor.org.uk/
CHD/an_paeds.nsf/vwContent/home [accessed August 2018].
Cardiology in the Young 7
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S104795111800224X
Downloaded from https://www.cambridge.org/core. University of Birmingham, on 22 Jan 2019 at 14:31:06, subject to the Cambridge Core terms of use, available at
